ABL1 | C-abl oncogene 1, non-receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
ADCK3 | AarF domain containing kinase 3 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Tissue enriched |
ADCK4 | AarF domain containing kinase 4 | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ADCK5 | AarF domain containing kinase 5 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
ADRBK1 | Adrenergic, beta, receptor kinase 1 | Enzymes Plasma proteins
| | | | | Expressed in all |
AKT1 | V-akt murine thymoma viral oncogene homolog 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
AKT2 | V-akt murine thymoma viral oncogene homolog 2 | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
ALPK1 | Alpha-kinase 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
ATM | Ataxia telangiectasia mutated | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
BCKDK | Branched chain ketoacid dehydrogenase kinase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
BRAF | V-raf murine sarcoma viral oncogene homolog B | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | | | | Expressed in all |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
CAMK2A | Calcium/calmodulin-dependent protein kinase II alpha | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
CAMK2B | Calcium/calmodulin-dependent protein kinase II beta | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
CAMKK2 | Calcium/calmodulin-dependent protein kinase kinase 2, beta | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
CAMKV | CaM kinase-like vesicle-associated | Enzymes
| | | | | Tissue enriched |
CASK | Calcium/calmodulin-dependent serine protein kinase (MAGUK family) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
CDC7 | Cell division cycle 7 | Enzymes Plasma proteins
| | | | | Mixed |
CDK1 | Cyclin-dependent kinase 1 | Cancer-related genes Enzymes Plasma proteins
| | | | | Mixed |
CDK11A | Cyclin-dependent kinase 11A | Enzymes
| | | | | Expressed in all |
CDK12 | Cyclin-dependent kinase 12 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CDK16 | Cyclin-dependent kinase 16 | Enzymes
| | | | | Expressed in all |
CDK20 | Cyclin-dependent kinase 20 | Enzymes
| | | | | Mixed |
CDK6 | Cyclin-dependent kinase 6 | Cancer-related genes Enzymes Plasma proteins
| | | | | Mixed |
CDK7 | Cyclin-dependent kinase 7 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
CDK9 | Cyclin-dependent kinase 9 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
CDKL5 | Cyclin-dependent kinase-like 5 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
CHUK | Conserved helix-loop-helix ubiquitous kinase | Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
CLK3 | CDC-like kinase 3 | Enzymes
| | | | | Expressed in all |
DCLK1 | Doublecortin-like kinase 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DCLK2 | Doublecortin-like kinase 2 | Cytoskeleton related proteins Enzymes
| | | | | Tissue enhanced |
DMPK | Dystrophia myotonica-protein kinase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
DSTYK | Dual serine/threonine and tyrosine protein kinase | Enzymes
| | | | | Mixed |
DYRK1A | Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EIF2AK3 | Eukaryotic translation initiation factor 2-alpha kinase 3 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
EPHB3 | EPH receptor B3 | Cancer-related genes Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ERBB2 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ERN1 | Endoplasmic reticulum to nucleus signaling 1 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
FASTK | Fas-activated serine/threonine kinase | Enzymes
| | | | | Expressed in all |
FGFR3 | Fibroblast growth factor receptor 3 | Cancer-related genes CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FLT1 | Fms-related tyrosine kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FYN | FYN oncogene related to SRC, FGR, YES | Enzymes Plasma proteins
| | | | | Expressed in all |
GRK6 | G protein-coupled receptor kinase 6 | Enzymes
| | | | | Expressed in all |
HIPK2 | Homeodomain interacting protein kinase 2 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
HUNK | Hormonally up-regulated Neu-associated kinase | Enzymes
| | | | | Mixed |
IKBKB | Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | Disease related genes Enzymes FDA approved drug targets Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
IRAK1 | Interleukin-1 receptor-associated kinase 1 | Enzymes
| | | | | Expressed in all |
KDR | Kinase insert domain receptor (a type III receptor tyrosine kinase) | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |